Page 42 - Journal of Special Operations Medicine - Spring 2016
P. 42

–   Level C: Expert opinion, case studies, or standards   7. Preliminary studies have shown that a chitosan-free
            of care.                                         version of XStat produces the same hemostatic efficacy
                                                             with decreased cost. Follow-on research should in-
          Using this taxonomy, the level of evidence for this change   clude  comparative  studies  using  a  chitosan-free  XStat
          is Level C.                                        application.

                                                             8. A smaller-diameter applicator to facilitate XStat de-
          Recommendations for                                livery to a narrower wound tract should also be evalu-
          Further Research and Development
                                                             ated. This also would potentially reduce the treatment
          1. Evaluate XStat as a potential adjunct to allow for   cost and provide added capability to treat smaller en-
          extremity and junctional tourniquet conversion. This   trance/wound tracts.
          would entail observation times of at least 6 hours and
          potentially as long as 72 hours if this product is intended   9. The Mueller and Cestero studies used only a 60- minute
          to help medics meet the proposed prolonged field care   observation time. Further studies should include longer
          goal of 72 hours of prehospital care.              observation periods (4 hours and beyond) so that the
                                                             utility of XStat for prolonged field-care scenarios may
          2. Additional research should be conducted comparing   be evaluated.
          XStat with both hemostatic dressings and junctional
          tourniquets in various large-animal bleeding models, in-
          cluding neck injury. This additional research should also   Acknowledgments
          include narrow-tract junctional wounds that approxi-  The authors gratefully acknowledge the research as-
          mate the width of the entrance tract from wounds from   sistance provided by Mrs Danielle Davis of the Joint
          military assault rifles (both 5.56mm and 7.62mm) with   Trauma System. The authors also thank the Department
          severe bleeding in the depths of the wound tract.  of Defense Trauma Registry for providing much of the
                                                             casualty data discussed in this paper and CAPT Zsolt
          3. If supported by the research findings, consideration   Stockinger for his review of earlier drafts of this paper
          should be given to approving XStat for use in neck   and CAPT (retired) Steve Giebner for his editorial as-
          wounds.                                            sistance on the manuscript.

          4. Some narrow-tract wounds may communicate with
          the thoracic or peritoneal spaces. What will happen if the   Disclaimer
          XStat minisponges are inadvertently injected into these   The opinions or assertions contained herein are the pri-
          spaces? Research is needed to address this question.  vate views of the authors and are not to be construed as
                                                             official or as reflecting the views of the Department of
          5. A research project should be undertaken as a com-  the Army or the Department of Defense. This recom-
          bined effort of the Joint Trauma System and the AFMES   mendation is intended to be a guideline only and is not
          to identify all casualties, including those killed in action   a substitute for clinical judgment.
          who are not entered in the DoD Trauma Registry, who
          sustained life-threatening hemorrhage from narrow-
          tract penetrating trauma. This effort should also note   Release
          whether the wounds were amenable to treatment with   This document was reviewed by the Director of the Joint
          limb tourniquets, hemostatic dressings, or junctional   Trauma System and by the Public Affairs Office and the
          tourniquets, and whether these devices were used.  Operational Security Office at the US Army Institute of
                                                             Surgical Research. It is approved for unlimited public
          6. The Joint Trauma System Performance Improve-    release.
          ment process should be used to identify all future ca-
          sualties on whom XStat is used and how it performed.
            Additionally, the records of casualties who would have   Disclosures
          been good candidates for hemorrhage control with   The authors have no disclosures.
          XStat (life-threatening hemorrhage from narrow-tract
          penetrating trauma not amenable to treatment with
          limb tourniquets, hemostatic dressings, or junctional   References
          tourniquets, or not responding to these treatment mo-  1.  Eastridge BJ, Mabry RL, Seguin P, et al. Death on the battle-
          dalities), but for whom XStat was not used, should   field (2001–2011): implications for the future of combat ca-
          also be identified and reviewed for opportunities to   sualty care. J Trauma Acute Care Surg. 2012;73(6 suppl 5):
          improve.                                             S431–437.



          26                                      Journal of Special Operations Medicine  Volume 16, Edition 1/Spring 2016
   37   38   39   40   41   42   43   44   45   46   47